because as soon as generic Zytiga hits the market, Xtandi will never be covered. MDVN refused to tell analysts even what it charges for its half drug. This is a cover up for fraud.
and VALE is #1 in nickel.
As a contractor, I don't rent anything anymore.
Patent expiration dates:
◦February 18, 2014
Patent use: USE IN COMBINATION WITH PREDNISONE FOR THE TREATMENT OF PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
since there are no barriers to entry. Margins are too low to make any money, but buying a ticket company at peak price was absolutely desperate.
all the gold it can to replace the U.S. dollar as the reserve currency of the World.
is nuts.and sounds desperate.. What is next- naming a stadium.
Only one of them is rare and scarce. The rest have a limitless supply that costs NOTHING.